EinkBro is designed to fit Eink devices' needs; no unnecessary UI transitions and animations, clear B&W icons, useful features for eink reading experience. It's originated from FOSS Browser, which is ...
PETALING JAYA: Citaglobal Bhd has entered into a joint development agreement (JDA) with Singapore-based Keppel Sustainability Solutions Pte Ltd to collaborate on bio-compressed natural gas (Bio-CNG) ...
ExxonMobil plans to sell 82.89% of Esso SAF and 100% of ExxonMobil Chemical France to North Atlantic Refining. The agreement includes the Notre-Dame-de-Gravenchon refinery, a steam cracker, and ...
Mirny wind project to also feature integrated 300MW/600MWh battery storage system to enhance grid reliability as Central Asian nation seeks to boost renewable energy share Chinese wind turbine giant ...
Canadian asset manager Sagard Capital is expanding its Manhattan footprint. The $27 billion Montreal-based firm inked a 10-year lease at SL Green and Vornado Realty Trust’s 280 Park Avenue, The Real ...
Chris Nelson is a credit cards writer for TPG. He specializes in budget travel, hotels, earning elite status through minimal spending and redeeming points for maximum value. Credit card writer Danyal ...
Once operational, it is expected to generate about 315 million units (MUs) annually and mitigate over 0.25 million tonnes of carbon dioxide emissions per year. New Delhi: Tata Power Renewable Energy ...
Following a billboard teaser in Philly, Ink & Dagger have announced that reissues of their entire catalog are coming out on Halloween (10/31) via Trust Records, the same label that’s been responsible ...
Though it hasn’t become the massive seller analysts once envisioned, Repatha has still become one of Amgen’s most lucrative products, recording $2.2 billion in revenue in 2024. However, like some of ...
“Ink Master” is back for Season 17, and this time the competition has a theme: “hometown heroes.” The show, hosted by Good Charlotte frontman Joel Madden (who also founded music companies Veeps and ...
Biotechnology firm Biocon on Wednesday said its unit has inked a settlement and license agreement with Amgen Inc., paving the way for commercialisation of two biosimilars used in the treatment of ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The firm was founded in D.C. in ...